September 1st, 2009, by Digital Davo | acne treatments, aczone
The FDA has issued a warning letter to Allergan, the makers of Aczone for overstating the efficacy of Aczone and also for understating the possible side effects. In a sign that the FDA is watching carefully the claims that vendors use when advertising their products, the warning letter calls out a journal advertisement for Aczone as violating the Federal Food, Drug, and Cosmetic Act. …
July 20th, 2009, by Digital Davo | acne treatments, clinical trials
An intriguing Clinical Trial has been listed on the ClinicalTrials.gov web site. The product know only as DER 45 EV Gel (in strengths of 1% and 5%) has been listed in a dose-range trial for the papules and pustules of rosacea. Clinical Trial NCT00940992, A Dose-Range of DER 45-EV in Treatment of Rosacea (SGT-EBPO1-09) …
January 17th, 2009, by Digital Davo | acne treatments, clinical trials, topicals
Just posted on the clinicaltrials.gov database is an entry “Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea”. This topical product, known as Ziana, is currently approved for the treatment of acne.
Ziana is …
October 28th, 2008, by Digital Davo | accutane, acne treatments, swelling
A question we hear from time to time from rosacea sufferers is `how do I go about reducing the size of my skin pores ?’ This is quite a difficult question to properly answer. The enlarged pores that you sometimes see with rosacea or acne can feel like they will never go away.
You are …
June 19th, 2008, by Digital Davo | acne treatments, aczone, in the news, topicals
OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m.
From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5%
“Aczone(R) Gel 5% …
|
|
|
|
|
|